Cargando…

Association between radiotherapy and risk of death from cardiovascular diseases in lung and bronchus cancer

BACKGROUND: Radiotherapy plays an important role in the treatment of lung cancer. However, radiation-related deaths from cardiovascular disease (CVD) are a concern in these patients, and few studies have examined CVD-related death associated with lung cancer. We aimed to evaluate the risk of CVD-rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Zhong, Zhang, Yu, Wang, Yu, Gao, Yun, Wang, Yanhong, Li, Xiangnan, Ru, Songwei, Guo, Na, Qiu, Jingxuan, Zhang, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877540/ https://www.ncbi.nlm.nih.gov/pubmed/36712270 http://dx.doi.org/10.3389/fcvm.2022.1068957

Ejemplares similares

Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases
por: Cai, Yang-Wei, et al.
Publicado: (2023)

Case report: Rare epithelioid hemangioendothelioma occurs in both main bronchus and lung
por: Gong, Jiuyu, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Suicide and Cardiovascular Death Among Patients With Multiple Primary Cancers in the United States
por: Su, Chen, et al.
Publicado: (2022)

Case report: A rare combination of right aortic arch with right patent ductus arteriosus and right tracheal bronchus causing impaired respiratory function
por: Lian, Xingchen, et al.
Publicado: (2022)

Effect of radiotherapy on cardiac-specific death in patients with non-malignant tumors of central nervous system and related clinical features
por: Wang, Ruxin, et al.
Publicado: (2022)

Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging
por: Podlesnikar, Tomaž, et al.
Publicado: (2022)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

A Novel Nomogram Based on a Competing Risk Model Predicting Cardiovascular Death Risk in Patients With Chronic Kidney Disease
por: Li, Ning, et al.
Publicado: (2022)

COVID-19 is associated with the risk of cardiovascular disease death: A two-sample Mendelian randomization study
por: Miao, Jia-peng, et al.
Publicado: (2022)

Editorial: Cardiovascular sequelae of chemotherapy and radiotherapy in cancer survivors: current evidence and perspectives
por: Felici, Tamara, et al.
Publicado: (2023)

Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects
por: Yu, Yani, et al.
Publicado: (2022)

Tracheal Bronchus
por: Kajihara, Yusaku
Publicado: (2022)

Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy
por: Xie, Yixin, et al.
Publicado: (2023)

Hyperhomocysteinemia Increases Risk of Metabolic Syndrome and Cardiovascular Death in an Elderly Chinese Community Population of a 7-Year Follow-Up Study
por: Liu, Chang, et al.
Publicado: (2022)

Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study
por: Zhao, Yuwei, et al.
Publicado: (2022)

Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
por: Jun, Qiu, et al.
Publicado: (2022)

Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank
por: Wang, Junren, et al.
Publicado: (2021)

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
por: Guan, Lihua, et al.
Publicado: (2023)

Association of Early and Supernormal Vascular Aging categories with cardiovascular disease in the Chinese population
por: Cao, Qiuyu, et al.
Publicado: (2022)

Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
por: Wang, Le, et al.
Publicado: (2021)

Osteoarthritis and cardiovascular disease: A Mendelian randomization study
por: Wang, Zhao, et al.
Publicado: (2022)

CircHIPK3 Plays Vital Roles in Cardiovascular Disease
por: Zhang, Lei, et al.
Publicado: (2021)

Negative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults
por: Bie, Lizhan, et al.
Publicado: (2022)

Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
por: Wang, Lun, et al.
Publicado: (2020)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Smoking, immunity, and cardiovascular prognosis: a study of plasma IgE concentration in patients with acute myocardial infarction
por: Zhang, Lili, et al.
Publicado: (2023)

Risk for Cardiovascular Death Associated With Waist Circumference and Diabetes: A 9-Year Prospective Study in the Wan Shou Lu Cohort
por: Li, Man, et al.
Publicado: (2022)

Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease
por: Li, Yuman, et al.
Publicado: (2021)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

A systematic review and meta-analysis of cold exposure and cardiovascular disease outcomes
por: Fan, Jie-Fu, et al.
Publicado: (2023)

The impact of tumor characteristics on cardiovascular disease death in breast cancer patients with CT or RT: a population-based study
por: Chi, Kaiyi, et al.
Publicado: (2023)

Mitigating the Risk of COVID-19 Deaths in Cardiovascular Disease Patients in Africa Resource Poor Communities
por: Okpara, Ihunanya Chinyere, et al.
Publicado: (2021)

The Associations of Lipid Profiles With Cardiovascular Diseases and Death in a 10-Year Prospective Cohort Study
por: Dong, Jiayi, et al.
Publicado: (2021)

The role of m5C methyltransferases in cardiovascular diseases
por: Wang, Yan-Yue, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is
por: Du, Lixin, et al.
Publicado: (2022)

Postload Plasma Glucose but Not Fasting Plasma Glucose Had a Greater Predictive Value for Cardiovascular Disease in a Large Prospective Cohort Study in Southwest China
por: Wang, Yingying, et al.
Publicado: (2022)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f956v4hu16p94uda0is4ntfia3